PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
Auto Draft
Auto Draft
Auto Draft
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper
Volume 8 Issue 1

Determining the Appropriate New Generation Test for Pyrogen-free Products

When determining a test for pyrogens and bacterial endotoxin, there are many regulations, needs, limitations, and techniques to consider. The original pyrogen test, ...
Continue Reading →
Volume 8 Issue 1

Navigating the Future of Pharmaceutical Oral Dose Manufacturing: Embracing the Rise of High Potency Drugs

The pharmaceutical industry is undergoing a trans- formative period, driven by advancements in technology, evolving patient needs, and the increasing demand for high...
Continue Reading →
Volume 8 Issue 1

Case Study: Development and Manufacture of a Highly Potent OSD Product

In the modern pharmaceutical industry, Contract Development and Manufacturing Organisations (CDMOs) have become integral players. However, this was not always the ca...
Continue Reading →
Volume 8 Issue 1

Building a Competitive Edge through Tailored CMC Strategies in Drug Development

The healthcare industry’s demand for safe, effective, and accessible advanced therapeutics is rising rapidly. Drug developers are becoming more competitive in the ra...
Continue Reading →
Volume 8 Issue 1

The Impact of Data and Academic Partnerships on Cold Chain Innovation

Cold chain logistics are vital in the pharmaceutical and life sciences industries, where temperature-sensitive products such as vaccines, medications, and biological...
Continue Reading →
Volume 8 Issue 1

Building a Patient Centric Supply Chain

Patient well-being should be at the heart of all decisions made within the life sciences. Despite this, other factors often compete for decision-makers' attention an...
Continue Reading →
Volume 8 Issue 1

Breath Analysis in Diagnostics: The Use of Animal Models

Developing breath analysis methodologies in mouse models has significant benefits for clinical research and in practice for a range of therapeutics. Sampling medi...
Continue Reading →
Volume 8 Issue 1

Patient-Derived Xenografts Strengthen Mouse Clinical Trials in Oncology Research

Patient-Derived Xenograft (PDX) mouse models involve implanting human tumour tissues into immunodeficient mice, preserving the original tumour's genetic and histolog...
Continue Reading →
Volume 8 Issue 1

Leveraging Liquid Biopsy to Advance Metastatic Cancer Care

Liquid Biopsy: A Non-Invasive Approach to Tumour Profiling Metastasis is responsible for 90% of cancer-related deaths, yet most treatments focus on primary disease. ...
Continue Reading →
Volume 7 Issue 4

Demonstrating Equivalence Between Recombinant Semaglutide APIs

This article presents a quality comparison between the recombinant origin Semaglutide drug substance made by Aurisco and the innovator’s injectable and oral Semaglut...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC